J.P. Morgan Upgrades Covidien (COV) to Overweight
Tweet Send to a Friend
J.P. Morgan upgrades Covidien (NYSE: COV) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
